bambuterol has been researched along with Alzheimer Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giacobini, E | 1 |
| Chen, Y; Li, Q; Sun, H; Yang, H | 1 |
| Du, C; Du, K; Feng, C; Lv, W; Shen, R; Sun, H; Xi, M | 1 |
| Li, X; Wang, S; Wang, Y; Wang, Z; Zhang, H | 1 |
| Huang, R; Klumpp-Thomas, C; Li, AJ; Li, S; Sakamuru, S; Travers, J; Xia, M; Xu, T | 1 |
3 review(s) available for bambuterol and Alzheimer Disease
| Article | Year |
|---|---|
Cholinesterases: new roles in brain function and in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Humans; Reference Values | 2003 |
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Topics: Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans | 2017 |
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Humans; Ligands | 2022 |
2 other study(ies) available for bambuterol and Alzheimer Disease
| Article | Year |
|---|---|
Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cell Line; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2022 |
Identification of Compounds for Butyrylcholinesterase Inhibition.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Structure-Activity Relationship; Terbutaline | 2021 |